Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients
{{output}}
Background: Only a few patients who experience AML relapse derive lasting benefit from re-induction therapy. The utility of reassessing the disease karyotype at relapse is unclear. The main goals of this study were to identify pr... ...
